Belloff Neil S. 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jul 30, 2021
Insider Transaction Report
Form 4
Belloff Neil S.
General Counsel and Secretary
Transactions
- Exercise/Conversion
Common Stock
2021-07-30+1,563→ 33,158 total - Tax Payment
Common Stock
2021-07-30$1.32/sh−459$606→ 32,699 total - Exercise/Conversion
Restricted Stock Units
2021-07-30−1,563→ 9,375 total→ Common Stock (1,563 underlying)
Footnotes (4)
- [F1]The restricted stock units issued to the reporting person onJanuary 30, 2019 have partially vested and settled for shares of the Issuer's common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F4]The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated with certain qualifying terminations of service or in connection with a corporate transaction.